These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15571074)

  • 1. The antimotility action of a trifluoromethyl ketone on some gram-negative bacteria.
    Spengler G; Molnár A; Klausz G; Mándi Y; Kawase M; Motohashi N; Molnár J
    Acta Microbiol Immunol Hung; 2004; 51(3):351-8. PubMed ID: 15571074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori.
    Spengler G; Molnar A; Klausz G; Mandi Y; Kawase M; Motohashi N; Molnar J
    Int J Antimicrob Agents; 2004 Jun; 23(6):631-3. PubMed ID: 15194136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a trifluoromethyl ketone on the motility of proton pump-deleted mutant of Escherichia coli strain and its wild-type.
    Molnár A; Wolfart K; Kawase M; Motohashi N; Molnár J
    In Vivo; 2004; 18(4):505-7. PubMed ID: 15369192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of trifluoromethyl ketones and their synergism with promethazine.
    Kawase M; Motohashi N; Sakagami H; Kanamoto T; Nakashima H; Ferenczy L; Wolfard K; Miskolci C; Molnár J
    Int J Antimicrob Agents; 2001 Aug; 18(2):161-5. PubMed ID: 11516939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trifluoromethyl ketones on the motility of Proteus vulgaris.
    Wolfart K; Molnar A; Kawase M; Motohashi N; Molnar J
    Biol Pharm Bull; 2004 Sep; 27(9):1462-4. PubMed ID: 15340240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors.
    Varga ZG; Armada A; Cerca P; Amaral L; Mior Ahmad Subki MA; Savka MA; Szegedi E; Kawase M; Motohashi N; Molnár J
    In Vivo; 2012; 26(2):277-85. PubMed ID: 22351670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
    Sharara AI
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.
    Tanaka M; Isogai E; Isogai H; Hayashi S; Hirose K; Kimura K; Sugiyama T; Sato K
    J Antimicrob Chemother; 2002 Jun; 49(6):1039-40. PubMed ID: 12039901
    [No Abstract]   [Full Text] [Related]  

  • 10. Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
    Nishizawa T; Suzuki H; Nakagawa I; Iwasaki E; Masaoka T; Hibi T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S167-70. PubMed ID: 19120892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotaxis and motility of Helicobacter pylori in a viscous environment.
    Yoshiyama H; Nakamura H; Kimoto M; Okita K; Nakazawa T
    J Gastroenterol; 1999; 34 Suppl 11():18-23. PubMed ID: 10616760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
    Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones.
    Kawase M; Harada H; Saito S; Cui J; Tani S
    Bioorg Med Chem Lett; 1999 Jan; 9(2):193-4. PubMed ID: 10021926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
    Huang LP; Zhuang ML; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):210-2. PubMed ID: 19292962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori.
    Tsugawa H; Suzuki H; Muraoka H; Ikeda F; Hirata K; Matsuzaki J; Saito Y; Hibi T
    Biochem Biophys Res Commun; 2011 Jan; 404(2):656-60. PubMed ID: 21147064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001.
    Rimbara E; Noguchi N; Tanabe M; Kawai T; Matsumoto Y; Sasatsu M
    Clin Microbiol Infect; 2005 Apr; 11(4):307-11. PubMed ID: 15760428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.